drugset / Trial / NCT00232934

Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients

NCT00232934

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether the association of Thalidomide to Melphalan and Prednisone is effective in the treatment of newly diagnosed elderly multiple myeloma.

Timeline

Start
2002-01
Primary completion
2005-01
Completion
2014-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Thalidomide Other / unclassified 100 mg Oral

Indications